review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes
Published 5 years ago • 74 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:18:19
nefrologia
-
1:10:53
november 21, 2022 nephrology vmr with dr. letícia rolon and dr. david li - hematuria & recurrent aki
-
2:31
cardiovascular kidney metabolic syndrome : a presidential advisory from the aha
-
1:03
nefroprotección en la diabetes: resultados con endpoint renales de los estudios con isglt2.
-
15:52
urea and uremia
-
4:36
monocytes and macrophages in kidney transplantation and insights from single cell rna-seq studies
-
43:09
doim gr 10/3: toward precision medicine for glomerular disease
-
14:03
diabetes dan heart failure part 2 - modul diabetes - dr. rulli r, sppd,kemd #diabetes #heartfailure
-
7:35
cardiac & renal outcomes with efpeglenatide in diabetes (amplitude-o) | nejm | med journal club
-
1:06:58
e-seminar #1 new pharmacological therapies to slow the progression of diabetic kidney disease
-
1:04:16
new pharmacological therapies to slow the progression of diabetic kidney disease e-seminar #4
-
3:20
#apolipoprotein b test of blood is to be done with all blood test of heart
-
1:31:41
kalbemed - webinar "nutrition and diabetes in kidney disease"
-
27:19
hipertensión conn hipokalemia
-
1:00:09
is the nephropathy damaging the lungs? or is it alveolar hemorrhage injuring the kidneys?
-
1:17:29
coronavirus y nefrología
-
59:16
sglt2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?
-
0:56
cardio kidney metabolic disease: it takes a team